150 participants
Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-08
- Start Date:
- 2025-05-31
- Completion:
- 2026-10-31
Conditions
- Atopic Dermatitis
Interventions
- DRUG
No Results Yet